IONS
Ionis Pharmaceuticals Inc
43.50$
-1.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 76.3% | 63.1% | 71.4% | 74.4% | 67.8% | 74.5% | 72.1% | 86.5% | 65.5% | 60.0% | 0.4% | 0.8% | 0.6% | 0.2% | 1.9% | 2.1% | 1.9% | 1.1% | 2.3% | 2.4% | 2.3% | 0.5% | 2.9% | 3.5% | 0.9% | 2.4% | 1.0% | 1.3% | 1.5% | 1.8% | 1.8% | 1.8% | 0.8% | 1.7% | 1.1% | 0.9% | 1.5% | 3.9% | 1.2% | 1.0% | 1.8% | |
| 23.7% | 36.9% | 28.6% | 25.6% | 32.2% | 25.5% | 100.0% | 100.0% | 100.0% | 40.0% | 99.6% | 99.2% | 99.4% | 99.8% | 98.1% | 97.9% | 98.1% | 98.9% | 97.7% | 97.6% | 97.7% | 99.5% | 97.1% | 96.5% | 99.1% | 97.6% | 99.0% | 98.7% | 98.5% | 98.2% | 98.2% | 98.2% | 99.2% | 98.3% | 98.9% | 99.1% | 98.5% | 96.1% | 98.8% | 99.0% | 98.2% | |
| 76.3% | 63.1% | 71.4% | 74.4% | 67.8% | 74.5% | 72.1% | 86.5% | 65.5% | 59.1% | 35.8% | 64.7% | 62.2% | 30.2% | 87.7% | 84.0% | 78.1% | 58.9% | 125.3% | 110.8% | 138.8% | 40.7% | 113.5% | 135.1% | 114.5% | 202.8% | 151.7% | 122.1% | 149.1% | 179.3% | 179.3% | 98.6% | 164.2% | 108.3% | 152.5% | 48.1% | 138.9% | 137.9% | 85.4% | 81.0% | 105.9% | |
| 9.2% | 11.3% | 11.8% | 19.9% | 22.6% | 26.5% | 30.2% | 56.2% | 47.3% | 34.4% | 23.0% | 45.9% | 35.8% | 16.9% | 56.2% | 49.5% | 42.7% | 47.8% | 51.2% | 35.9% | 22.6% | 8.8% | 24.0% | 25.3% | 21.5% | 31.5% | 34.9% | 24.5% | 48.5% | 44.1% | 44.1% | 28.9% | 46.0% | 38.9% | 58.0% | 20.0% | 61.8% | 64.1% | 61.1% | 56.1% | 60.4% | |
| 9.2% | 11.3% | 11.8% | 19.9% | 22.6% | 26.5% | 102.3% | 142.7% | 112.8% | 34.4% | 58.8% | 110.7% | 97.9% | 47.0% | 143.9% | 133.5% | 120.9% | 106.7% | 180.1% | 155.7% | 162.2% | 49.4% | 137.6% | 160.4% | 136.1% | 234.5% | 186.4% | 146.5% | 197.8% | 223.3% | 223.3% | 127.5% | 210.3% | 147.2% | 210.4% | 68.2% | 200.7% | 202.0% | 146.5% | 137.2% | 166.2% | |
| 14.5% | 25.7% | 16.8% | 5.7% | 9.6% | -1.0% | -2.3% | -42.7% | -12.8% | 5.6% | 40.9% | -11.5% | 1.5% | 52.8% | -45.8% | -35.6% | -22.8% | -7.8% | -82.4% | -58.0% | -64.5% | 50.1% | -40.5% | -63.9% | -37.0% | -137.0% | -87.5% | -47.9% | -99.3% | -125.1% | -125.1% | -29.3% | -111.1% | -48.9% | -111.6% | 30.9% | -102.2% | -105.9% | -47.7% | -38.2% | -68.1% | |
| 8.8% | 6.2% | 9.8% | 10.5% | 9.1% | 6.3% | 7.6% | 9.4% | 7.8% | 6.0% | 3.9% | 7.2% | 7.1% | 2.7% | 1.7% | 1.7% | 1.5% | 0.8% | 2.2% | 1.9% | 1.8% | 0.5% | 1.5% | 1.6% | 1.3% | 1.1% | 13.1% | 10.6% | 15.2% | 18.5% | 18.5% | 10.1% | 17.0% | 10.1% | 17.4% | 5.0% | 14.1% | 11.2% | 9.1% | 8.3% | 10.2% | |
| 6.6% | 18.0% | 7.7% | -2.6% | -5.5% | -6.9% | -7.5% | -47.7% | -13.7% | 5.6% | 41.0% | -10.3% | 2.1% | 48.3% | -39.7% | -24.4% | -19.7% | -8.1% | -80.4% | -64.1% | -62.9% | 51.1% | -45.1% | -76.9% | -29.2% | -29.2% | -86.5% | -41.1% | -97.6% | -119.4% | -119.4% | -29.4% | -107.7% | -47.2% | -111.6% | 27.3% | -81.9% | -112.3% | -37.5% | -42.3% | -64.3% | |
| 8.8% | 1.8% | 8.6% | 0.2% | 0.8% | -4.2% | 0.0% | 0.3% | 0.3% | -152.0% | 10.4% | -4.2% | -8.9% | 6.9% | -2.3% | 1.4% | 3.2% | 109.5% | 0.1% | 0.3% | -1.0% | 0.1% | 0.8% | 1.7% | 0.2% | 5.3% | 8.7% | 4.2% | 4.6% | 0.1% | 0.1% | 0.0% | -2.7% | -1.2% | 0.1% | 0.0% | 0.1% | 0.5% | 0.1% | -0.5% | 0.0% | |
| 6.6% | 16.1% | 7.7% | -2.7% | -2.2% | 1.6% | -1.0% | -34.3% | -3.1% | 166.6% | 28.4% | -0.5% | 15.6% | 37.4% | -29.7% | -17.6% | -15.3% | -117.2% | -80.5% | -64.3% | -62.0% | 51.0% | -45.9% | -78.6% | -29.4% | -34.5% | -95.2% | -45.3% | -102.2% | -119.5% | -119.5% | -29.4% | -105.0% | -46.1% | -111.6% | 27.3% | -82.1% | -112.8% | -37.6% | -42.8% | -64.6% | |
| 17.5% | 25.6% | 19.6% | 10.1% | 5.8% | 0.0% | 2.0% | -35.8% | -3.7% | 13.4% | 46.3% | -0.6% | 11.4% | 51.8% | -35.5% | -19.9% | -15.4% | -2.6% | -74.7% | -59.3% | -58.7% | 51.6% | -41.1% | -72.5% | -25.5% | -24.3% | -70.1% | -27.5% | -79.6% | -97.5% | -97.5% | -16.8% | -87.7% | -35.5% | -91.2% | 33.2% | -65.9% | 2,269.7% | -27.8% | -39.3% | 495.6% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.